Pricing
  1. US-listed companies
  2. Ampio Pharmaceuticals, Inc.
  3. Financials
  4. Cash from operations

Ampio Pharmaceuticals, Inc.【AMPE】

Market cap
$317.9K
P/E ratio
SummaryFinancials
Period EndCash from operations (Million USD)YoY (%)
Dec 31, 2023-9-59.47%
Dec 31, 2022-21+49.96%
Dec 31, 2021-14-4.16%
Dec 31, 2020-15-4.44%
Dec 31, 2019-15+26.73%
Dec 31, 2018-12+6.40%
Dec 31, 2017-11-22.00%
Dec 31, 2016-15-44.69%
Dec 31, 2015-26-13.98%
Dec 31, 2014-31+60.67%
Dec 31, 2013-19+96.94%
Dec 31, 2012-10+6.39%
Dec 31, 2011-9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)